Dr Eddie Wang
Projects as PI
- Cellular and viral immunology resource (23/04/2006 - 22/01/2010)
- Characterisation of a novel class of natural killer cell immunoevasin (01/05/2021 - 28/02/2025)
- Commercial supply of DR3 Knock out (01/04/2015 - 29/02/2016)
- DR3 knockout (01/08/2012 - 31/07/2013)
- Exploring innate-like and adaptive gamma delta T cell paradigms in health and disease (01/03/2021 - 28/02/2026)
Projects as Co-Investigator
- Development of human CMV as a vaccine vector (01/10/2018 - 31/07/2019)
- Development of novel CD200:CD200R blockade cancer immunotherapy (01/06/2015 - 31/05/2016)
- Diagnostic and therapeutic potential of ADCC in COVID-19 (05/08/2020 - 31/03/2021)
- Evaluation of novel CD200:CD200R blockade cancer immunotherapy (01/08/2016 - 06/04/2018)
- Examination Systems for Biological Systems (28/11/2022 - 31/03/2023)